Company / SG&A per Share
Tango Therapeutics, Inc. SG&A per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.39
FY2025
5-year range
$0.20 / $0.43
FY2021-FY2025
Trend
-10.0%
vs FY2024
Sector context
#182 of 210
Health Care
What the data says
Tango Therapeutics, Inc.'s sg&a per share of $0.39 is lower than 87% of companies in the Health Care sector (FY2025). Improved from $0.40 to $0.39 over the past 2 years.
Based on SEC 10-K filings.
0.39 in FY2025 with a 5-year CAGR of +4.5%.
Improved from $0.40 to $0.39 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +24.2%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 210This company $0.39 Sector average $40.75
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 10.0% year-over-year.
- Ranks #182 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2024.
- Lowest sg&a per share in the period was in FY2022.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.39 | -10.0% |
| FY2024 | $0.43 | +6.3% |
| FY2023 | $0.40 | +100.1% |
| FY2022 | $0.20 | -17.7% |
| FY2021 | $0.24 | -20.9% |
| FY2020 | $0.31 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026